chromatin proteins modifications drug targets
plethora groundbreaking studies demonstrated importance chromatin-associated proteins post-translational modifications histones proteins dna so-called epigenetic modifications transcriptional control normal development disruption epigenetic control frequent event disease first epigenetic-based therapies cancer treatment approved generation new classes potent specific inhibitors several chromatin-associated proteins shown promise preclinical trials although biology epigenetic regulation complex new inhibitors will hopefully clinical use coming years
